{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-005308","form_type":"8-K","ticker":"PIII","cik":"0001832511","company_name":"P3 Health Partners Inc.","filed_at":"2025-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.161442+00:00","generated_at":"2026-05-26T22:23:34.544506+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"P3 Health Partners provides preliminary 2025 guidance; proposes $30M note from largest shareholder","bullets":["Preliminary 2025 revenue guidance of $1.35B-$1.5B; Adjusted EBITDA of $(35)M to $5M.","At-risk members guidance of 108k-118k for FY2025.","Proposed $30M unsecured promissory note and warrants from largest shareholder, terms similar to Dec 2024 financing.","CEO states $130M+ EBITDA growth initiatives on track; targeting profitability in 2025.","Full 2025 guidance to be issued with Q4 2024 earnings."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-005308","json":"https://secwatch.observer/filing/0001628280-25-005308.json","markdown":"https://secwatch.observer/filing/0001628280-25-005308.md","text":"https://secwatch.observer/filing/0001628280-25-005308.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832511/000162828025005308/0001628280-25-005308-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832511/000162828025005308/piii-20250213.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T22:23:34.544506+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}